CoChat

20 years of the European IVF-monitoring Consortium registry: what have we learned? A comparison with registries from two other regions

Open access
De Geyter, Ch, Wyns, C, Calhaz-Jorge, C, de Mouzon, J, Ferraretti, A P, Kupka, M, Nyboe Andersen, A, Nygren, K G, Goossens, V · 2020 · Human Reproduction

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

STUDY QUESTION: How has the performance of the European regional register of the European IVF-monitoring Consortium (EIM)/European Society of Human Reproduction and Embryology (ESHRE) evolved from 1997 to 2016, as compared to the register of the Centres for Disease Control and Prevention (CDC) of the USA and the Australia and New Zealand Assisted Reproduction Database (ANZARD)? SUMMARY ANSWER: It was found that coherent and analogous changes are recorded in the three regional registers over time, with a different intensity and pace, that new technologies are taken up with considerable delay and that incidental complications and adverse events are only recorded sporadically. WHAT IS KNOWN ALREADY: European data on ART have been collected since 1997 by EIM. Data collection on ART in Europe is particularly difficult due to its fragmented political and legal landscape. In 1997, approximately 78.1% of all known institutions offering ART services in 23 European countries submitted data and in 2016 this number rose to 91.8% in 40 countries. STUDY DESIGN, SIZE, DURATION: We compared the changes in European ART data as published in the EIM reports (2001–2020) with those of the USA, as published by CDC, and with those of Australia and New Zealand, as published by ANZARD. PARTICIPANTS/MATERIALS, SETTING, METHODS: We performed a retrospective analysis of the published EIM data sets spanning the 20 years observance period from 1997 to 2016, together with the published data sets of the USA as well as of Australia and New Zealand. By comparing the data sets in these three large registers, we analysed differences in the completeness of the recordings together with differences in the time intervals on the occurrence of important trends in each of them. Effects of suspected over- and under-reporting were also compared between the three registers. X2 log-rank analysis was used to assess differences in the data sets. MAIN RESULTS AND THE ROLE OF CHANCE: During the period 1997–2016, the numbers of recorded ART treatments increased considerably (5.3-fold in Europe, 4.6-fold in the USA, 3.0-fold in Australia and New Zealand), while the number of registered treatment modalities rose from 3 to 7 in Europe, from 4 to 10 in the USA and from 5 to 8 in Australia and New Zealand, as published by EIM, CDC and ANZARD, respectively. The uptake of new treatment modalities over time has been very different in the three registers. There is a considerable degree of underreporting of the number of initiated treatment cycles in Europe. The relationship between IVF and ICSI and between fresh and thawing cycles evolved similarly in the three geographical areas. The freeze-all strategy is increasingly being adopted by all areas, but in Europe with much delay. Fewer cycles with the transfer of two or more embryos were reported in all three geographical areas. The delivery rate per embryo transfer in thawing cycles bypassed that in fresh cycles in the USA in 2012, in Australia and New Zealand in 2013, but not yet in Europe. As a result of these changing approaches, fewer multiple deliveries have been reported. Since 2012, the most documented adverse event of ART in all three registers has been premature birth (<37 weeks). Some adverse events, such as maternal death, ovarian hyperstimulation syndrome, haemorrhage and infections, were only recorded by EIM and ANZARD. LIMITATIONS, REASONS FOR CAUTION: The methods of data collection and reporting were very different among European countries, but also among the three registers. The better the legal background on ART surveillance, the more complete are the data sets. Until the legal obligation to report is installed in all European countries together with an appropriate quality control of the submitted data the reported numbers and incidences should be interpreted with caution. WIDER IMPLICATIONS OF THE FINDINGS: The growing number of reported treatments in ART, the higher variability in treatment modalities and the rising contribution to the birth rates over the last 20 years point towards the increasing impact of ART. High levels of completeness in data reporting have been reached, but inconsistencies and inaccuracies still remain and need to be identified and quantified. The current trend towards a higher diversity in treatment modalities and the rising impact of cryostorage, resulting in improved safety during and after ART treatment, require changes in the organization of surveillance in ART. The present comparison must stimulate all stakeholders in ART to optimize surveillance and data quality assurance in ART. STUDY FUNDING/COMPETING INTEREST(S): This study has no external funding and all costs are covered by ESHRE. There are no competing interests. TRIAL REGISTRATION NUMBER: N/A.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/deaa250

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. The number of treatments with various forms of ART from 1997 to 2016. ANZARD, Australia and New Zealand Assisted Reproduction Database; CDC, the Centres for Disease Control and Prevention; ED, egg donation; EIM, the European IVF-monitoring Consortium; FET, frozen embryo transfer; FOR, frozen oocyte replacement; PGT, preimplantation genetic testing.
Figure 1. The number of treatments with various forms of ART from 1997 to 2016. ANZARD, Australia and New Zealand Assisted Reproduction Database; CDC, the Centres for Disease Control and Prevention; ED, egg donation; EIM, the European IVF-monitoring Consortium; FET, frozen embryo transfer; FOR, frozen oocyte replacement; PGT, preimplantation genetic testing.CC BY-NC · PubMed Central
Figure 1. Continued.
Figure 1. Continued.CC BY-NC · PubMed Central
Figure 2. The number of initiated fresh cycles with IVF + ICSI, the number of aspirations of oocytes and the number of cycles with embryo transfers.
Figure 2. The number of initiated fresh cycles with IVF + ICSI, the number of aspirations of oocytes and the number of cycles with embryo transfers.CC BY-NC · PubMed Central
Figure 3. Proportion of single embryo transfers, transfers with two embryos and transfers with three or more embryos.
Figure 3. Proportion of single embryo transfers, transfers with two embryos and transfers with three or more embryos.CC BY-NC · PubMed Central
Figure 4. Deliveries per embryo transfer in fresh cycles and in thawing cycles. The arrows point towards the year in which the number of deliveries after thawing cycles exceed the number of deliveries after fresh cycles.
Figure 4. Deliveries per embryo transfer in fresh cycles and in thawing cycles. The arrows point towards the year in which the number of deliveries after thawing cycles exceed the number of deliveries after fresh cycles.CC BY-NC · PubMed Central
Figure 5. Changes in the numbers of infants born after IVF, ICSI and FET.
Figure 5. Changes in the numbers of infants born after IVF, ICSI and FET.CC BY-NC · PubMed Central
Figure 6. Changes in the proportion of premature deliveries (in singleton, twin and triplet (or higher grade)) pregnancies after ART.
Figure 6. Changes in the proportion of premature deliveries (in singleton, twin and triplet (or higher grade)) pregnancies after ART.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 3

  1. De Geyter, 2019, Assisted Reproductive Technology Surveillance
  2. Luke, 2019, Assisted Reproductive Technology Surveillance
  3. Toner, 2019, Assisted Reproductive Technology Surveillance, 172

Cited by

Items 201–208 of 208

Metadata

Authors
De Geyter, C., Wyns, C., Calhaz-Jorge, C., de Mouzon, J., Ferraretti, A. P., Kupka, M., Nyboe Andersen, A., Nygren, K. G., & Goossens, V
Affiliations
  • Reproductive Medicine and Gynecological Endocrinology (RME), University Hospital, University of Basel, Basel, Switzerland
  • Cliniques Universitaires Saint-Luc (BE)
  • Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
  • Institut National de Santé et de la Recherche Médicale, Service de Gynécologie Obstétrique II et de Médecine de la Procréation, Groupe Hospitalier Cochin-Saint Vincent de Paul, Paris, France
  • S.I.S.Me.R. Reproductive Medicine Unit, Bologna, Italy
  • Fertility Center—Gynaekologicum, Hamburg, Germany
  • The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
  • European Society of Human Reproduction and Embryology (BE)
Venue
Human Reproduction
Published
2020-11-14
Volume
35
Issue
12
Pages
2832-2849
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W3100377772
Cited by
195
References
39
Citations by year
2026: 15 · 2025: 37 · 2024: 36 · 2023: 55 · 2022: 35 · 2021: 17
FWCI
23.59
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Funders
European Society of Human Reproduction and Embryology
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
assisted reproduction, ESHRE, registry data completeness, adverse events, technology adoption, Australia and New Zealand
MeSH terms
Australia, Europe, Female, Fertilization in Vitro, Humans, New Zealand, Pregnancy, Registries, Retrospective Studies, Pregnancy Rate, Sperm Injections, Intracytoplasmic, Reproductive Techniques, Assisted

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.